I know we're here talking about drugs reviewed and then placed on formularies, but I'm trying to get back to the earlier stage that talks about how easily and how quickly we approve drugs in the first place, particularly with this whole thing about not all side effects being known. For example, we might have a clinical trial that goes for two years and the negative side effects might not show up for seven years. In other words, before we worry about what we're going to pay for and what we're going to put on the formulary, shouldn't we be absolutely sure that we're only licensing drugs in a very rigorous manner?
Dr. Morgan, would you respond to that?